MENU
OCS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Oculis Holding AG (OCS) Ownership - Who owns Oculis Holding AG?
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care... Show more
Profile
Industry
N/A
Address
Bahnhofstrasse 7
Phone
+41 417119325
Employees
N/A
Web
https://www.oculis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.04B
P/E Ratio
63.08
Total Cash
181.93M
Projected Growth
N/A
Total Debt
1.1M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.49
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
OCS
Capitalization
1.04B
P/E Ratio
63.08
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
182M
Total Cash/Share
3.49
Total Debt
1.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
163M
P/B Ratio
5.22
Cash Flow
N/A
Earnings
-2.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
555K
Current Ratio
4.79
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-101.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-67.94
Shares Held By Institutions
65.8M
Shares Outstanding - Current
52.1M
Total Liabilities
41.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
17.176
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Bahnhofstrasse 7
Phone
+41 417119325
Employees
N/A
Web
https://www.oculis.com